Dr Hoyoung Huh MD PhD
Naia Board of Advisors
Dr Huh is a distinguished thought leader in the healthcare industry with extensive experience in international markets and inter-country business transactions.
He is currently chairman of the board of Geron Corporation and Cytomx Therapeutics, as well as a director of ADDEX Pharmaceuticals and AntriaBio, Inc. Previously, he was chairman of the board of directors of BiPar Sciences, Inc, a wholly-owned subsidiary of Sanofi-Aventis, and also served as its president and CEO. Additionally, Dr Huh serves on the boards of directors of several privately-held companies. He held several senior positions at Nektar Therapeutics, including chief operating officer and senior vice president of business development and marketing. Prior to Nektar, Dr Huh was a partner at McKinsey & Company where he was in the biotechnology and biopharmaceutical sectors. Prior to McKinsey, he was a physician and researcher at Cornell University Medical College and Memorial Sloan-Kettering Cancer Center.
Dr Huh holds an AB in biochemistry from Dartmouth College and an MD and a PhD in genetics and cell biology from Cornell University Medical College and Sloan-Kettering Institute.